top of page
Search

Dry Eye Syndrome Market Exceeds USD 5.2 Billion in 2023, Projected to Surge with 4.21% CAGR by 2030

  • Writer: Amit Kumar
    Amit Kumar
  • Jan 24, 2024
  • 3 min read


MarkNtel Advisors who is leading market research company, has recently published a research report, titled Global “Dry Eye Syndrome Market”. The report is estimated historical data, base year and forecast period and the projections are made for the next five years, i.e., 2024-30. The data, facts, and figures are sourced from reliable platforms, including government portals, white papers, and others.


For a better understanding to download a free sample PDF of this study -https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html 


Market Study Period

Historical Data: 2019-22

Base Year: 2023

Forecast Period: 2024-30

CAGR (2024-2030): 4.21%


Global Dry Eye Syndrome Market Insights:

The Global Dry Eye Syndrome Market size is valued at around USD 5.2 billion in 2023 and is projected to grow at a CAGR of around 4.21% during the forecast period, i.e., 2024-30. The report covers each and every aspect of the market in detail, offering actionable insights to the stakeholders. We extensively cover key trends, opportunities, possible challenges, and major growth drivers for the industry. The report also highlights the role and involvement of governments and other relevant factors that promote market growth.


Global Dry Eye Syndrome Market Drivers:

Growing Number of Eye Care Centers Prompting Surge in Product Utilization – The prevalence of dry eye disease has been increasing worldwide, owing to various reasons such as environmental conditions, hormonal changes, a rise in the geriatric population, autoimmune disorders, etc. This has resulted in a spike in eye clinics & centers globally for treatment. Additionally, the blossoming of eye care centers is majorly driven by the steady boost in professionals, such as ophthalmologists & optometrists. While the number of ophthalmologists is expected to remain stable, the number of optometrists is presumed to raise.

Optometrists offer services through private practices, chain/mass merchandisers, and government organizations. Independent optometrists can differentiate themselves by providing personalized care, building patient loyalty, and offering clinical care. Hence, this allows them to offer a higher level of service to the patients. Thus, the growing number of eye care centers is prompting a surge in product utilization of DED & would propel its demand in the forecast years..


Explore the Complete Dry Eye Syndrome Market Analysis Report - https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html


Which segments are covered in the Dry Eye Syndrome Market Research Report?

  • By Product

  • Artificial Tears

  • Anti-inflammatory Drugs

  • Cyclosporine-

  • Corticosteroid-

  • Punctal Plugs

  • Dissolvable-

  • Removable-

  • Others (Secretagogues, Oral drugs, etc.)

  • By Disease Type

  • Aqueous Dry Eye

  • Evaporative Dry Eye

  • By Distribution Channel

  • Offline

  • Retail Pharmacies

  • Hospital Pharmacies

  • Online

  • By Competition

  • Competition Characteristics

  • Market Share Analysis

  • By Region

  • North America

  • South America

  • Europe

  • Middle East & Africa

  • Asia-Pacific


Top 10 Key Brands/Players in the Dry Eye Syndrome Market

Our analysts have closely analyzed leading players within the industry, providing stakeholders with valuable insights into the competitive landscape. This enables them to formulate strategic tactics based on the comprehensive data compiled in the report. The information encompasses recent developments, mergers and acquisitions, product/service launches, expansion plans, and revenue-generating opportunities. Notable entities featured in the report include:

  • Mitotech Pharma

  • ReGen Tree

  • Santen Pharmaceutical

  • HanAll BioPharma

  • Sun Pharma

  • Novaliq

  • Sylentis

  • Alcon

  • Horus Pharma

  • Johnson & Johnson

  • Alderya Therapeutics

  • Visufarma

  • Allergan

  • Prestige Consumer Health

  • Others


For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/dry-eye-disease-drugs-market.html


Frequently Asked Questions

  1. Which companies dominate the Dry Eye Syndrome Market in terms of market share?

  2. What is the projected market size of Dry Eye Syndrome Market in 2030?

  3. What key factor is anticipated to propel the Dry Eye Syndrome Market by 2030?

  4. How big is the Dry Eye Syndrome Market?


Other Reports –


About us:

Confronting a market challenge? MarkNtel is here to support you. We specialize in in-depth analysis across 15 dynamic industries, providing customized research, consulting, and data solutions to meet your specific requirements. Whether it's launching a product or gaining a competitive edge, we facilitate well-informed decisions that pave the way for enduring success.

 

Empowering your financial future is our commitment at MarkNtel. Serving as your trusted research partner, we navigate intricate markets, pinpoint high-potential opportunities, and formulate early-stage strategies for superior returns. Allow us to illuminate your path to financial prosperity.


Contact us:

Should you have any inquiries, our team of seasoned experts is available to help. You can contact us via phone, email, or by filling out our online contact form. Be assured that we will exert every effort to promptly attend to your query and furnish the necessary information.


Media Representative

Phone: +1 628 895 8081

 
 
 

Comments

bottom of page